Document is current
Any future updates will be listed below
-
Authors
Branco, Diogo R.
Alves, Mariana
Severiano E Sousa, Catarina
Costa, João
Ferreira, Joaquim J.
Caldeira, Daniel https://orcid.org/0000-0002-2520-5673
-
Funding
Funding for this research was provided by:
Universidade de Lisboa
- License Information
-
More Information
Article History
Accepted: 3 June 2023
First Online: 5 July 2023
Declarations
:
: DC: has participated in educational meetings and/or attended a conferences or symposia (including travel, accommodation and/or hospitality) with Bristol-Myers Squibb, Bayer, BIAL, Boehringer Ingelheim, Daiichi Sankyo, Merck Serono, Ferrer, Pfizer, Novartis and Roche. JJF: received grants from GlaxoSmithKline, Grunenthal, Fundação MSD (Portugal), TEVA, MSD, Allergan, Novartis, Medtronic. He received consultancy fees from GlaxoSmithKline, Novartis, TEVA, Lundbeck, Solvay, BIAL, Merck-Serono, Merz, Ipsen, Biogen, Acadia, Allergan, Abbvie, Sunovion Pharmaceuticals, Zambon, Affiris. He also participated in advisory boards for Bial and expert testimony to Novartis. DB, MA, CS and JC do not have conflict of interests to report.
